Carson Wealth (CWM LLC)’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$176 Hold
26
﹤0.01% 5542
2025
Q4
$0 Hold
26
﹤0.01% 5442
2025
Q3
$0 Hold
26
﹤0.01% 5352
2025
Q2
$0 Hold
26
﹤0.01% 5167
2025
Q1
$0 Hold
26
﹤0.01% 5098
2024
Q4
$0 Hold
26
﹤0.01% 4980
2024
Q3
$0 Sell
26
-401
-94% -$6.05K ﹤0.01% 4915
2024
Q2
$10K Buy
427
+352
+469% +$10.9K ﹤0.01% 3536
2024
Q1
$4K Buy
75
+32
+74% +$1.38K ﹤0.01% 3756
2023
Q4
$1K Buy
43
+17
+65% +$256 ﹤0.01% 3950
2023
Q3
$1K Hold
26
﹤0.01% 3978
2023
Q2
$2K Hold
26
﹤0.01% 3789
2023
Q1
$12K Hold
26
﹤0.01% 2850
2022
Q4
$10K Hold
26
﹤0.01% 2793
2022
Q3
$8K Hold
26
﹤0.01% 2807
2022
Q2
$7K Hold
26
﹤0.01% 2794
2022
Q1
$8K Hold
26
﹤0.01% 2614
2021
Q4
$9K Buy
+26
New +$8.1K ﹤0.01% 2405
2021
Q2
$17K Hold
26
﹤0.01% 1861
2021
Q1
$17K Hold
26
﹤0.01% 1861
2020
Q4
$17K Hold
26
﹤0.01% 1861
2020
Q3
$17K Hold
26
﹤0.01% 1861
2020
Q2
$17K Hold
26
﹤0.01% 1861
2020
Q1
$17K Hold
26
﹤0.01% 1861
2019
Q4
$17K Hold
26
﹤0.01% 1861
2019
Q3
$17K Hold
26
﹤0.01% 1861
2019
Q2
$17K Hold
26
﹤0.01% 1861
2019
Q1
$17K Buy
+26
New +$35.3K ﹤0.01% 1861

Other funds holding KYNB

Carson Wealth (CWM LLC)'s KYNB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its Kyntra Bio (KYNB) position steady in Q1 2026 at 26 shares worth $176. The position accounts for ﹤0.01% of the portfolio, ranked #5542.

Carson Wealth (CWM LLC) first reported a position in KYNB in Q1 2019 and has held it in 28 quarters since. The position peaked at $17K in Q2 2021. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 26 shares of Kyntra Bio worth $176 as of Q1 2026.
  • Carson Wealth (CWM LLC) left its Kyntra Bio share count unchanged in Q1 2026.
  • Kyntra Bio made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5542 holding.
  • Carson Wealth (CWM LLC) first reported a position in Kyntra Bio in Q1 2019 and has held it in 28 quarters since.
  • Carson Wealth (CWM LLC)'s Kyntra Bio position peaked at $17K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.